Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride

Chonbuk National University

Status

Completed

Conditions

Hyperlipidemias

Treatments

Dietary Supplement: Angelica gigas N. extract

Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT03079648

WBP-HL-AG1

Details and patient eligibility

About

This study was conducted to investigate the effects of daily supplementation of Angelica gigas N. extract on improvement of Blood Triglyceride.

Full description

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Angelica gigas N. extract or a placebo group. Fasting triglyceride profiles before and after the intervention.

Enrollment

100 patients

Sex

All

Ages

19 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age 19-80 years with Triglyceride 130-200 mg/dL

Exclusion criteria

Lipid lowering agent within past 6 months
Severe cardiovascular disease(Mvocardial infarction, Stroke, etc)
Renal disease(Heredity hyperlipidemia, Acute/Chronic renal failure, Nephrotic syndrome, etc)
Cancer, Respiratory organ disease(Asthma, Chronic obstructive pulmonary disease)
Autoimmune disease
Diabetes mellitus
Allergic or hypersensitive to any of the ingredients in the test products
History of disease that could interfere with the test products or impede their absorption
Under antipsychotic drugs therapy within past 2 months
History of alcohol or substance abuse
Participation in any other clinical trials within past 2 months
Laboratory test by show the following results
- aspartate aminotransferase, alanine aminotransferase > Reference range upper limit treble
- Serum Creatinine > 2.0 mg/dl
Pregnancy or breast feeding
Not Contraception(except: Surgery for female infertility)